Dr. Swisher heads the Division of Surgery at The University of Texas MD Anderson Cancer Center. He is on the executive leadership team of the lung cancer initiative in MD Anderson’s Moon Shots Program™ — the boldest-ever research effort to dramatically reduce deaths to cancer.

After graduating Phi Beta Kappa from Stanford University, where he completed dual bachelor’s degrees with distinction in history and biology, Dr. Swisher earned his medical degree from the University of California at San Diego School of Medicine. There he garnered Surgery Honors and the Lange Publications Award. He completed a general surgery residency and a fellowship in surgical oncology at the University of California, Los Angeles (UCLA) Medical Center, where he received the Golden Scalpel Chief Resident Award for outstanding teaching. He also served as a surgery registrar as part of his residency at the University of Nottingham in Nottingham, England.

Dr. Swisher’s assumed his first academic appointment at UCLA Medical Center as a clinical instructor in the Division of Surgery. He came to Houston in 1994 for a residency in cardiothoracic surgery at MD Anderson and St. Luke’s Episcopal Hospital/Texas Heart Institute, focusing on thoracic surgical oncology. In 1996 he joined MD Anderson’s faculty as assistant professor in the Department of Thoracic and Cardiovascular Surgery. He has continually risen through the faculty ranks, achieving associate professor in 2001 and early promotion to professor in 2005. He became chair of his department after a national search in 2007 and was awarded the Robert F. Fly Professorship of Surgical Oncology. In 2014, following a highly competitive national search, he was named head of the Division of Surgery and awarded the Charles A. LeMaistre Distinguished Chair in Thoracic Oncology.

Dr. Swisher is repeatedly listed among the top doctors and surgeons in Texas and the nation. Other accolades include the Resident Clinical Teaching Award from The University of Texas Medical School at Houston, which honored his dedication to educating the next generation of cancer experts.

An author of more than 430 peer-reviewed publications who is on the review board of multiple surgical and oncology journals such as Lancet Oncology, World Journal of Surgical Oncology and The Annals of Surgical Oncology. Dr. Swisher is internationally recognized for his pioneering gene therapy clinical trials in lung and esophageal cancer using adenovirus-p53 and adenovirus-TNFα. His current translational research efforts focus on developing a novel small molecule lung cancer treatment (Stat-3 inhibitor oncrasin-72) and on revealing the prognostic and therapeutic role of the PKR/eIF2α biomarker. His research has been supported by the Department of Defense and the National Institutes of Health/National Cancer Institute (NCI).

Dr. Swisher is a member of numerous professional organizations and has served on many national and institutional committees. He is currently a member of the Lung Committee in SWOG (an NCI-supported cancer clinical trial cooperative group), a member of the Lung Cancer Working Group of the American Society of Clinical Oncologists, a d an ALCHEMIST Core Committee member for NCI’s Cancer Therapy Evaluation Program.

Dr Ola Khorshid is currently a Prof. of Medical Oncology, Malignant Hematology & BMT, Medical Oncology Department NCI, Cairo University
She is the Chairman & Founder of Millennium HealthCare institution
Chairman of Onco thoracic International Clinical Association OnTiC
Cofounder of Orchid Oncology Center
Secretary General of the Mediterranean Multidisciplinary Oncology Forum (MMOF)
She received her master (1998) and PhD (2004) degrees in medical oncology and hematological malignancies from the NCI Cairo University. She has been ESMO certified since 2006
She has trained in MD Anderson Cancer center 2002 and was a Post Doctoral Fellow in MDAnderson Cancer center, Blood and Marrow transplant department,
Developer of Medical oncology curriculum for Medical Oncology Fellowship for the Egyptian Fellowship Board 2008
She is an examiner in the Master & PhD degree of Medical Oncology Cairo University.
She is also an examiner for the Kenyan oncology board.
She was Secretary General of the Egyptian Hemato Oncology Group (EHOG) 2008-2011

She was the clinical instructor and Medical oncologist at Dar Al Fouad Hospital during the period from August 2004 to June 2005: was the person in charge of developing the SOP and all requirements for the Joint Committee of International Accreditation

She is the winner of the Cairo University Achievement Award for 2011

Dr Khorshid is currently an assistant editor of MEDITERRANEAN ONCOLOGY JOURNAL –M.O.J
She has numerous international publications in SCT, hematological malignancies and solid tumor.
Her main research interest is in Lung, GU, Breast Cancer, GIT malignancies,Lymphoma, Leukemia & BMT

• I am a Saudi physician with more than 23 years experience in the healthcare sector with an excellent clinical and academic profile in Radiology
• Through continuous learning, gaining knowledge and expertise in healthcare finance/economics and performance management, I have built on my clinical and radiology
experience to further improve what I do for patients
• I believe we can improve patient’s care including imaging with less but more valuable care

Dr. Maya Romani is an assistant professor of family medicine and the director of the health and wellness center at the American University of Beirut (AUB). She is a certified tobacco training specialist from Duke, US, and in charge of the current smoking cessation program and clinic at AUB. Dr. Romani is a lifestyle medicine specialist, diplomate of the international board of lifestyle medicine, and a certified corporate wellness specialist. She is also certified in medication education and is currently the associate director of the family medicine residency program at AUB. She has published several book chapters and research articles in peer-review journals

Prof. Khaled Al-Kattan, Dean College of Medicine, Alfaisal University and Consultant Thoracic Surgery and lung transplant at King Faisal Specialist Hospital & Research Centre. He was a graduate from King Saud University 1983, got his FRCS from Edinburgh with a gold medal in 1988. Appointed as an assistance professor at KSU in 1989, Associate professor in 1995 and then a full professor in 2000. He served as the director of continuous medical education at the college. He was a co-founder of both the Saudi thoracic society and Pan Arab Chest Society. He is the Middle East regent for the European Society of Thoracic Surgery. He is a member of many international societies as IASLC and sits as a senior editor for the Annals of Thoracic Medicine journal. He is in the editorial board and reviewer of most of the international thoracic surgery journals. Have extensive research and publication in his field, presented many abstracts in international symposiums. Was invited as an international speaker in many medical events. He is the founder of the National Lung Cancer Study Group and the national lung transplant program. Have contributed to public health education and establishment of several charity medical associations.

Director of Innovations and Research and Director of International Program at Cincinnati Cancer Advisors, Cincinnati, OH, USA.
CEO of Innovative Healthcare Institute, Cincinnati, OH, USA.
Founding Editor in Chief, Global Journal on Quality and Safety in Healthcare.
Former Chairman and Professor, Department of Oncology and a Professor at King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia between 2006-2020.
Former Professor and Chief of Hematology Oncology Division at University of Cincinnati. Dr Jazieh founded the MENA-NCCN Collaborating Center (KSA) and the Association of VA Hematology Oncology (www.avaho.org) (USA).
Dr. Jazieh won multiple honors including Proclamation to the City of Cincinnati, naming a day in the City as Dr Abdul Rahman Jazieh Day in 2006 and Special Recognition from NCCN as Global Partner in Cancer Care 2018.